# FENC (Fennec Pharmaceuticals Inc.) - SEC EDGAR Financial Statements

> Fennec Pharmaceuticals Inc. reported $66.37M in revenue and net income of $2.03M for the trailing twelve months ended September 30, 2026 (up 57.3% year over year), with a 5.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/FENC
- Markdown: https://convexityos.com/fundamentals/FENC.md
- SEC CIK: 0001211583
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:38 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001211583&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $66.37M | +57.3% YoY |
| Operating Income | TTM | $3.72M | 5.6% margin |
| Net Income | TTM | $2.03M | 3.1% net margin |
| Diluted EPS | TTM | $0.05 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $48.68M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $44.64M | $47.54M | $21.25M | $1.53M | -- | $200K | $0 | $0 | $0 | $0 |
| Cost of Revenue | -- | -- | $1.26M | $86K | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | -- | -- | $19.99M | $1.45M | -- | -- | -- | -- | -- | -- |
| Research & Development | $250K | $307K | $56K | $3.53M | $4.98M | $5.11M | $5.61M | $5.01M | $1.94M | $472K |
| Selling, General & Admin | $46.91M | $41.48M | $32.71M | $20.51M | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $50.92M | $44.97M | $34.02M | $24.04M | $17.22M | $18.05M | $13.01M | -- | -- | -- |
| **Operating Income** | -$6.28M | $2.57M | -$12.77M | -$22.59M | -$17.22M | -$17.89M | -$13.01M | -$10.41M | -$6.95M | -$2.87M |
| Interest Income | $787K | $1.68M | $441K | -- | -- | -- | -- | -- | -- | -- |
| Interest Expense | $2.08M | $4.07M | $3.39M | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$9.63M | -$71K | -$16.05M | -- | -- | -- | -- | -- | -$7.05M | -$2.79M |
| Income Tax Expense | $106K | $365K | -- | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$9.74M | -$436K | -$16.05M | -$23.71M | -$17.35M | -$18.11M | -$12.78M | -$9.89M | -$7.05M | -$2.79M |
| Basic EPS | -$0.34 | -$0.02 | -$0.60 | -$0.90 | -$0.67 | -$0.76 | -$0.64 | -$0.52 | -$0.47 | -$0.22 |
| **Diluted EPS** | -$0.34 | -$0.02 | -$0.60 | -$0.90 | -$0.67 | -$0.76 | -$0.64 | -$0.52 | -$0.47 | -$0.22 |
| Basic Shares Outstanding | 28.6M | 27.3M | 26.6M | 26.3M | 26.0M | 23.7K | 19.9M | 18.9M | 15.0M | 12.8M |
| Diluted Shares Outstanding | 28.6M | 27.3M | 26.6M | 26.3M | 26.0M | 23.7K | 19.9M | 18.9M | 15.0M | 12.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $19.61M | $17.87M | $15.11M | $13.78M | $12.46M | $9.65M | $8.75M | $7.92M |
| Research & Development | $154K | $118K | $49K | $20K | $29K | $107K | $94K | $50K |
| Selling, General & Admin | $13.96M | $15.30M | $14.61M | $14.55M | $11.96M | $11.31M | $9.09M | $8.14M |
| Total Operating Expenses | $14.95M | $16.14M | $15.23M | $16.33M | $12.65M | $12.38M | $9.56M | $8.86M |
| **Operating Income** | $4.65M | $1.74M | -$119K | -$2.55M | -$189K | -$2.73M | -$808K | -$934K |
| Interest Income | $319K | $287K | $339K | $228K | $152K | $171K | $236K | $399K |
| Interest Expense | $1.0K | $3.0K | $7.0K | $308K | $586K | $594K | $592K | $966K |
| Income Before Tax | $4.97M | $2.02M | -- | -- | -$638K | -$3.15M | -- | -- |
| Income Tax Expense | $332K | $42K | -- | $106K | $0 | $0 | $0 | -- |
| **Net Income** | $4.64M | $1.97M | $201K | -$4.79M | -$638K | -$3.15M | -$1.17M | -$1.99M |
| Basic EPS | $0.13 | $0.06 | $0.01 | -- | -$0.02 | -$0.11 | -$0.04 | -- |
| **Diluted EPS** | $0.12 | $0.05 | $0.01 | -- | -$0.02 | -$0.11 | -$0.04 | -- |
| Basic Shares Outstanding | 35.1M | 34.5M | 34.3M | -- | 27.9M | 27.7M | 27.6M | -- |
| Diluted Shares Outstanding | 38.1M | 36.4M | 35.5M | -- | 27.9M | 27.7M | 27.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $36.79M | $26.63M | $13.27M | $12.40M | $23.77M | $21.10M | $30.34M | $13.65M | $22.78M | $28.26M |
| **Cash & Short-Term Investments** | $36.79M | $26.63M | $13.27M | $12.40M | $23.77M | $21.10M | $30.34M | $13.65M | $22.78M | $28.26M |
| Other Current Assets | $1.73M | $466K | $44K | $20K | $63K | $253K | $276K | $8.0K | $1.0K | $13K |
| **Total Current Assets** | $67.04M | $44.12M | $26.86M | $19.90M | $26.73M | $22.39M | $31.42M | $13.88M | $22.95M | $28.40M |
| Other Non-Current Assets | $717K | $822K | $816K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $3.51M | $822K | $6.0K | $82K | $211K | $27K | $0 | $262K | $0 | $0 |
| **Total Assets** | $70.55M | $44.95M | $26.86M | $19.98M | $26.94M | $22.41M | $31.42M | $14.15M | $22.95M | $28.40M |
| Accounts Payable | $4.63M | $3.24M | $3.78M | $2.94M | $2.39M | $777K | $1.57M | $1.61M | $1.03M | $855K |
| Deferred Revenue (Current) | $248K | $248K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $10.52M | $6.92M | $7.55M | $3.91M | $4.61M | $1.65M | $2.35M | $2.27M | $1.64M | $1.64M |
| Long-Term Debt | -- | $19.34M | $30.93M | $25.64M | $24.90M | $5.00M | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $24.56M | $24.56M | $2.0K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $24.56M | $43.90M | $30.93M | $25.65M | $24.90M | $4.99M | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $35.08M | $50.82M | $38.49M | $29.56M | $29.51M | $6.64M | $2.35M | $2.27M | $1.64M | $1.64M |
| **Total Debt (incl. Leases)** | -- | $19.34M | $30.95M | $25.67M | $24.90M | $5.00M | -- | -- | -- | -- |
| Common Stock | $189.9M | $145.6M | $144.3M | $143.6M | $142.6M | $140.8M | $140.7M | $106.4M | $106.4M | $103.0M |
| Retained Earnings | -$229.4M | -$219.7M | -$219.2M | $215.6M | -$203.2M | -$179.5M | -$162.1M | -$144.0M | -$131.3M | -$121.4M |
| Accumulated Other Comp. Income | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M |
| **Total Stockholders' Equity** | $35.47M | -$5.87M | -$11.62M | -$10.53M | -$2.57M | $15.77M | $29.07M | $11.88M | $21.31M | $26.76M |
| Total Equity | $35.47M | -$5.87M | -$11.62M | -$10.53M | -$2.57M | $15.77M | $29.07M | $11.88M | $21.31M | $26.76M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $48.68M | $41.25M | $40.18M | $36.79M | $21.95M | $18.70M | $22.68M | $26.63M |
| **Cash & Short-Term Investments** | $48.68M | $41.25M | $40.18M | $36.79M | $21.95M | $18.70M | $22.68M | $26.63M |
| Other Current Assets | $1.42M | $1.98M | $2.62M | $1.73M | $898K | $965K | $1.00M | $466K |
| **Total Current Assets** | $80.95M | $72.50M | $66.88M | $67.04M | $46.06M | $40.79M | $42.98M | $44.12M |
| Other Non-Current Assets | $640K | $666K | $691K | $717K | $743K | $768K | $794K | $822K |
| **Total Non-Current Assets** | $2.59M | $3.25M | $4.94M | $3.51M | $3.20M | $4.08M | $3.43M | $822K |
| **Total Assets** | $83.54M | $75.75M | $71.82M | $70.55M | $49.26M | $44.88M | $46.40M | $44.95M |
| Accounts Payable | $4.61M | $5.52M | $6.28M | $4.63M | $5.87M | $5.94M | $5.28M | $3.24M |
| Deferred Revenue (Current) | $2.81M | $3.18M | $248K | $248K | $248K | $248K | $248K | $248K |
| **Total Current Liabilities** | $13.24M | $12.39M | $9.59M | $10.52M | $9.81M | $8.41M | $8.37M | $6.92M |
| Long-Term Debt | -- | -- | -- | -- | $19.38M | $19.36M | $19.35M | $19.34M |
| Deferred Revenue (Non-Current) | $21.11M | $20.92M | $24.56M | $24.56M | $24.56M | $24.56M | $24.56M | $24.56M |
| **Total Non-Current Liabilities** | $21.11M | $20.92M | $24.56M | $24.56M | $43.94M | $43.92M | $43.91M | $43.90M |
| **Total Liabilities** | $34.35M | $33.31M | $34.15M | $35.08M | $53.75M | $52.34M | $52.28M | $50.82M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | $19.38M | $19.36M | $19.35M | $19.34M |
| Common Stock | $194.1M | $193.2M | $191.2M | $189.9M | $147.7M | $146.2M | $146.0M | $145.6M |
| Retained Earnings | -$222.6M | -$227.2M | -$229.2M | -$229.4M | -$224.6M | -$224.0M | -$220.8M | -$219.7M |
| Accumulated Other Comp. Income | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M | $1.24M |
| **Total Stockholders' Equity** | $49.19M | $42.44M | $37.67M | $35.47M | -$4.49M | -$7.46M | -$5.88M | -$5.87M |
| Total Equity | $49.19M | $42.44M | $37.67M | $35.47M | -$4.49M | -$7.46M | -$5.88M | -$5.87M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$9.74M | -$436K | -$16.05M | -$23.71M | -$17.35M | -$18.11M | -$12.78M | -$9.89M | -$7.05M | -$2.79M |
| Stock-Based Compensation | $7.03M | $5.06M | $5.35M | $4.09M | $3.75M | $2.79M | $2.67M | $1.82M | $1.52M | $615K |
| Change in Receivables | -$12.44M | -$7.87M | -$7.27M | -$1.54M | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$1.28M | $579K | -$1.58M | -$576K | -- | -- | -- | -- | -- | -- |
| Change in Payables | $1.39M | -$537K | $1.39M | $1.61M | -$794K | -$41K | $580K | $177K | $611K | -$54K |
| **Operating Cash Flow** | -$12.47M | $26.98M | -$17.14M | -$18.06M | -$14.22M | -$15.60M | -$9.06M | -$7.83M | -$3.64M | -$2.12M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | $31.97M | $0 | $0 | $27.38M | $5.00M |
| **Financing Cash Flow** | $22.63M | -$13.62M | $6.64M | $20.73M | $4.98M | $32.29M | -$71K | $2.35M | $27.98M | $5.11M |
| **Net Change in Cash** | $10.15M | $13.37M | -$10.51M | $2.67M | -$9.24M | $16.69M | -$9.13M | -$5.48M | $24.33M | $2.98M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $4.64M | $1.97M | $201K | -$4.79M | -$637K | -$3.15M | -$1.17M | -$1.99M |
| Stock-Based Compensation | $1.35M | $1.77M | $990K | $2.52M | $2.22M | $1.49M | $798K | $1.12M |
| Change in Receivables | -$528K | -$4.22M | $4.51M | -$3.46M | -$3.44M | -$265K | -$5.28M | -$175K |
| Change in Inventory | $257K | -$518K | -$291K | $139K | -$276K | -$797K | -$344K | $65K |
| Change in Payables | -$909K | -$765K | $1.65M | -$1.23M | -$75K | $661K | $2.04M | -$626K |
| **Operating Cash Flow** | $6.68M | $50K | $2.38M | -$5.96M | $1.49M | -$3.69M | -$4.32M | -$1.47M |
| **Financing Cash Flow** | $753K | $1.02M | $1.01M | $20.80M | $1.75M | -$284K | $359K | -$12.21M |
| **Net Change in Cash** | $7.43M | $1.07M | $3.39M | $14.84M | $3.24M | -$3.97M | -$3.96M | -$13.69M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | 94.1% | 94.4% | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -14.1% | 5.4% | -60.1% | -1471.6% | -- | -8942.5% | -- | -- | -- | -- |
| **Net Profit Margin** | -21.8% | -0.9% | -75.5% | -1544.9% | -- | -9054.5% | -- | -- | -- | -- |
| Return on Equity (ROE) | -27.5% | -- | -- | -- | -110.0% | -62.3% | -107.6% | -46.4% | -26.3% | -78.1% |
| Return on Assets (ROA) | -13.8% | -1.0% | -59.7% | -88.0% | -77.4% | -57.6% | -90.3% | -43.1% | -24.8% | -70.2% |
| Current Ratio | 6.37x | 6.38x | 3.56x | 5.80x | 13.54x | 13.39x | 6.11x | 14.02x | 17.28x | -- |
| Quick Ratio | 3.50x | 3.85x | 1.76x | 5.16x | 12.76x | 12.93x | 6.01x | 13.92x | 17.19x | 9.77x |
| Debt to Equity | -- | -- | -- | -- | 0.32x | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -6.1% | +123.7% | +1284.5% | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | +1279.8% | -- | -- | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -344.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -146.2% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -81.5% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -375.0% | -- | -100.0% |
| 10Y Net Income / Share Growth | -- | -- | -418.1% | -- | -100.1% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 5.6% | -1.9% | -11.0% | -14.1% | -12.0% | -29.1% | -38.8% | 5.4% |
| **Net Profit Margin** | 3.1% | -5.5% | -16.4% | -21.8% | -17.9% | -36.1% | -46.7% | -0.9% |
| Return on Equity (ROE) | 4.1% | -7.7% | -22.2% | -27.5% | -- | -- | -- | -- |
| Return on Assets (ROA) | 2.4% | -4.3% | -11.7% | -13.8% | -14.1% | -26.8% | -31.1% | -1.0% |
| Current Ratio | 6.11x | 5.85x | 6.98x | 6.37x | 4.69x | 4.85x | 5.13x | 6.38x |
| Quick Ratio | 3.68x | 3.33x | 4.19x | 3.50x | 2.24x | 2.22x | 2.71x | 3.85x |
| **Revenue Growth (YoY)** | +57.3% | +85.2% | +72.6% | +73.8% | +78.7% | +32.9% | -65.5% | -18.6% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -105.9% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -109.1% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -108.5% | -- |
| Operating Cash Flow Growth (YoY) | +347.6% | -- | -- | -- | -- | -- | -111.1% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
